- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01998724
Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial (LEAP)
October 2, 2018 updated by: Gloria Y. Yeh, Beth Israel Deaconess Medical Center
The main purpose of this study is to determine the feasibility and effects of a 6-month tai chi exercise program as compared to a 6-month group walking program and standard care for patients with COPD that have recently completed a pulmonary rehabilitation program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, United States, 02130
- VA Healthcare System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COPD defined as FEV1 (Forced expiratory volume in 1 second)/FVC (Forced vital capacity) <0.70 or chest CT evidence of emphysema
- Age > 40 years
- Any severity of COPD as defined by GOLD (Global Obstructive Lung Disease) stages 1, 2,3, or 4
- Completion of standard pulmonary rehabilitation of at least 8 weeks duration within 24 weeks prior to study entry* *Defined as attending 65% of the program's sessions with a minimum of 10 sessions
Exclusion Criteria:
- COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline
- Hypoxemia on walk test (O2 sat < 85% on oxygen)
- Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test
- Clinical signs of unstable cardiovascular disease (ie. chest pain on walk test)
- Severe cognitive dysfunction (documented Mini-Mental Status Exam ≤ 24)
- Non-English speaking
- Current regular practice of tai chi
- Current diagnosis of lung cancer or treated for lung cancer within the past 5 years
- Unstable/untreated mental health issue that precludes informed consent or otherwise affects ability to participate in the intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard Care
No intervention
|
|
|
Experimental: Tai Chi Exercise
24 week Tai Chi intervention designed for individuals with COPD
|
24 week tai chi intervention designed for individuals with COPD
|
|
Experimental: Group Walking Exercise
24 week group walking intervention
|
24 week group walking intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of tai chi intervention
Time Frame: 24 weeks
|
Willingness to participate, adherence, and safety
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline - Disease specific quality of life
Time Frame: Baseline, 12 weeks, 24 weeks, 1 year
|
Chronic Respiratory Questionnaire
|
Baseline, 12 weeks, 24 weeks, 1 year
|
|
Change from baseline - Exercise capacity
Time Frame: Baseline, 12 weeks, 24 weeks
|
Six minute walk distance
|
Baseline, 12 weeks, 24 weeks
|
|
Change from baseline - Dyspnea
Time Frame: Baseline, 12 weeks, 24 weeks, 1 year
|
University of California, San Diego Shortness of Breath Questionnaire
|
Baseline, 12 weeks, 24 weeks, 1 year
|
|
Change from baseline - Psychosocial well-being
Time Frame: Baseline, 12 weeks, 24 weeks, 1 year
|
Center for Epidemiologic Studies Depression Scale, Perceived Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Perceived Social Support
|
Baseline, 12 weeks, 24 weeks, 1 year
|
|
Changes from baseline - Pulmonary function
Time Frame: Baseline, 12 weeks, 24 weeks
|
Spirometry
|
Baseline, 12 weeks, 24 weeks
|
|
Change from baseline - Exercise Efficacy
Time Frame: Throughout study
|
Daily exercise activities, step counts taken at baseline, 12 weeks, 24 weeks, 1 year
|
Throughout study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gloria Yeh, MD, MPH, BIDMC, Harvard Medical School
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gilliam EA, Kilgore KL, Liu Y, Bernier L, Criscitiello S, Litrownik D, Wayne PM, Moy ML, Yeh GY. Managing the experience of breathlessness with Tai Chi: A qualitative analysis from a randomized controlled trial in COPD. Respir Med. 2021 Aug;184:106463. doi: 10.1016/j.rmed.2021.106463. Epub 2021 May 15.
- Moy ML, Wayne PM, Litrownik D, Beach D, Klings ES, Davis RB, Yeh GY. Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi. Contemp Clin Trials. 2015 Nov;45(Pt B):458-467. doi: 10.1016/j.cct.2015.09.004. Epub 2015 Sep 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
January 1, 2018
Study Completion (Actual)
September 1, 2018
Study Registration Dates
First Submitted
November 25, 2013
First Submitted That Met QC Criteria
November 25, 2013
First Posted (Estimate)
December 2, 2013
Study Record Updates
Last Update Posted (Actual)
October 3, 2018
Last Update Submitted That Met QC Criteria
October 2, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012P000220
- R01AT006358 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Clinical Trials on Tai Chi
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompleted
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Chengdu University of Traditional Chinese MedicineNot yet recruitingQuality of Life | Dialysis; Complications | Chinese Medicine
-
Jinan University GuangzhouChaozhou Special Education SchoolActive, not recruitingAutism Spectrum Disorder (ASDChina
-
University Hospital, Clermont-FerrandCompleted
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Hartford HospitalRecruiting
-
Texas Tech University Health Sciences CenterCompleted
-
Chang Gung Memorial HospitalCompleted
-
Massachusetts General HospitalUnknown